
Sign up to save your podcasts
Or


Today we're breaking down the latest information about Johnson & Johnson's COVID-19 vaccine.
Earlier this week, the U.S. put the use of this particular vaccine on hold because of new questions about a potential rare, but serious, side effect: blood clots in the brain.
So what does the data show right now? How worried should we really be about this? What does it mean for the other types of COVID-19 vaccines available?
We're getting those answers and more from the Executive Director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health, Dr. William Moss.
This episode is brought to you by Fitbod.me/newsworthy and BetterHelp.com/newsworthy
Get ad-free episodes by becoming an insider: www.theNewsWorthy.com/insider
By Erica Mandy4.7
13021,302 ratings
Today we're breaking down the latest information about Johnson & Johnson's COVID-19 vaccine.
Earlier this week, the U.S. put the use of this particular vaccine on hold because of new questions about a potential rare, but serious, side effect: blood clots in the brain.
So what does the data show right now? How worried should we really be about this? What does it mean for the other types of COVID-19 vaccines available?
We're getting those answers and more from the Executive Director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health, Dr. William Moss.
This episode is brought to you by Fitbod.me/newsworthy and BetterHelp.com/newsworthy
Get ad-free episodes by becoming an insider: www.theNewsWorthy.com/insider

2,330 Listeners

7,045 Listeners

10,448 Listeners

1,220 Listeners

4,925 Listeners

688 Listeners

6,698 Listeners

6,442 Listeners

5,390 Listeners

5,169 Listeners

1,902 Listeners

1,241 Listeners

3,372 Listeners

642 Listeners

15,332 Listeners